Corrected human papillomavirus vaccination rates for each birth fiscal year in Japan
| Autor: | Satoshi Nakagawa, Kosuke Hiramatsu, Yutaka Ueda, Tadashi Kimura, Asami Yagi, Sayaka Ikeda |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
0301 basic medicine
Cancer Research Adolescent media_common.quotation_subject Uterine Cervical Neoplasms Fiscal year 03 medical and health sciences 0302 clinical medicine Japan vaccine medicine Humans Papillomavirus Vaccines Adverse effect Child governmental suspension of recommendation vaccination rate media_common Estimation Cervical cancer Vaccination rate business.industry Papillomavirus Infections Epidemiology and Prevention General Medicine Original Articles medicine.disease Human papillomavirus vaccination Vaccination 030104 developmental biology Oncology 030220 oncology & carcinogenesis Female Immunization Original Article business fiscal year Welfare Demography |
| Zdroj: | Cancer Science |
| ISSN: | 1349-7006 |
| Popis: | In Japan, the serious adverse events after human papillomavirus (HPV) vaccination were widely reported in the media. The Ministry of Health, Labour and Welfare of Japan (MHLW) announced the suspension of the governmental recommendation of HPV vaccine in 2013, and the inoculation rate has since sharply declined. The estimated inoculation rate for each birth fiscal year (FY) announced by the MHLW and the actual numbers for each birth FY surveyed by local governments were very different. In particular, the cumulative vaccination rate of girls born in FY2000 was regarded to be as high as 42.9% by the Council of the MHLW. However, this estimation included a confusion. When the suspension of the governmental recommendation was announced in FY2013, the girls born in FY2000 turned 13 years old, the targeted starting age of the HPV vaccination. The vaccination rate of this generation is considered to be quite low. The numbers were recalculated in this study. This study revealed that the real vaccination rate is only 14.3%. Female individuals born in or after FY2000 have been confirmed to be exposed to the same cervical cancer risk as before the HPV vaccine was introduced in Japan. Corrected human papillomavirus vaccination rate for each birth fiscal year in Japan. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text